SIGMAR1 and myocardial ischemia: To address this limitation and more closely mimic the clinical reality, we started administering fluvoxamine, a well-established Sig-1R agonist, one day after the induction of myocardial ischemia–reperfusion in rats to simulate ischemia and drug administration early after ischemia injury in a realistic context.